{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:14:33Z","timestamp":1794651273699,"version":"4.9.1"},"reference-count":50,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Histopathologic diagnosis of adenocarcinoma of the prostate is based on light-microscopic examination of hematoxylin-eosin\u2013stained tissue sections. Multiple factors, including preanalytic and analytic elements, affect the ability of the pathologist to accurately diagnose prostatic adenocarcinoma. False-negative diagnosis, that is, failure to diagnose prostatic adenocarcinoma, may have serious clinical consequences. It is important to delineate and understand those factors that may affect and cause histopathologic false-negative diagnoses of prostatic adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To review common factors involved in histopathologic underdiagnosis of prostatic adenocarcinoma, including the following: (1) tissue processing and sectioning artifacts, (2) minimal adenocarcinoma, (3) deceptively benign appearing variants of acinar adenocarcinoma, (4) single cell adenocarcinoma, and (5) treatment effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Data sources included published, peer-reviewed literature and personal experiences of the senior author.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Knowledge of the reasons for histopathologic false-negative diagnosis of adenocarcinoma of the prostate is an important component in the diagnostic assessment of prostate tissue sections. Diagnostic awareness of the histomorphologic presentations of small (minimal) adenocarcinoma; deceptively benign appearing variants including atrophic, foamy gland, microcystic, and pseudohyperplastic variants; single cell carcinoma; and treatment effects is critical for establishment of a definitive diagnosis of adenocarcinoma and the prevention of false-negative diagnoses of prostate cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0456-ra","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:14:50Z","timestamp":1573816490000},"page":"326-334","source":"Crossref","is-referenced-by-count":23,"title":["False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma"],"prefix":"10.5858","volume":"144","author":[{"given":"Chen","family":"Yang","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"2020081300440763300_i1543-2165-144-3-326-b01","first-page":"87","article-title":"Histopathology of prostate cancer","author":"Humphrey","year":"2019","journal-title":"Prostate Cancer"},{"issue":"2","key":"2020081300440763300_i1543-2165-144-3-326-b02","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b03","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0b013e3181c3ece9","article-title":"False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up","volume":"34","author":"Wolters","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b04","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2559.2006.02409.x","article-title":"Detection of prostate cancer by \u03b1-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy","volume":"48","author":"Carswell","year":"2006","journal-title":"Histopathology"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b05","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pros.23128","article-title":"Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer","volume":"76","author":"Bonkhoff","year":"2016","journal-title":"Prostate"},{"issue":"5","key":"2020081300440763300_i1543-2165-144-3-326-b06","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5858\/2006-130-617-MAOEIP","article-title":"Medicolegal aspects of error in pathology","volume":"130","author":"Troxel","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"2020081300440763300_i1543-2165-144-3-326-b07","first-page":"2408","article-title":"Artefacts: a diagnostic dilemma\u2014a review","volume":"7","author":"Rastogi","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"2020081300440763300_i1543-2165-144-3-326-b08","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jclinpath-2011-200533","article-title":"The value of triple antibody (34\u03b2E12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins","volume":"65","author":"Al Daoud","year":"2012","journal-title":"J Clin Pathol"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b09","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAI.0000000000000599","article-title":"34BetaE12 and alpha-methylacyl coenzyme A racemase (AMACR) antibodies better than p63 antibody distinguish normal and neoplastic glands in prostatic tissue with thermal artifacts","volume":"27","author":"Pierconti","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2020081300440763300_i1543-2165-144-3-326-b10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.anndiagpath.2016.08.002","article-title":"Frozen section evaluation of margins in radical prostatectomy specimens: a contemporary study and literature review","volume":"24","author":"Nunez","year":"2016","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b11","first-page":"543","article-title":"Minimal carcinoma in prostate needle biopsy specimens","volume":"11","author":"Thorson","year":"1998","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5858\/2000-124-0098-CFBDOM","article-title":"Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation","volume":"124","author":"Iczkowski","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2559.2011.03990.x","article-title":"Diagnosis of limited adenocarcinoma of the prostate","volume":"60","author":"Epstein","year":"2012","journal-title":"Histopathology"},{"issue":"10","key":"2020081300440763300_i1543-2165-144-3-326-b14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00000478-199210000-00008","article-title":"Incidental lymphocytic prostatitis: selective involvement with nonmalignant glands","volume":"16","author":"Blumenfeld","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"2020081300440763300_i1543-2165-144-3-326-b15","first-page":"138","article-title":"Tumors of the prostate","author":"Humphrey","year":"2016","journal-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed"},{"issue":"8","key":"2020081300440763300_i1543-2165-144-3-326-b16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00000478-199708000-00007","article-title":"Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process","volume":"21","author":"Egan","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ajcp\/109.6.695","article-title":"Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens","volume":"109","author":"Kaleem","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2020081300440763300_i1543-2165-144-3-326-b18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000478-199703000-00004","article-title":"Adenocarcinoma of the prostate with atrophic features","volume":"21","author":"Cina","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e3181d2a549","article-title":"Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns","volume":"34","author":"Yaskiv","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081300440763300_i1543-2165-144-3-326-b20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.humpath.2004.06.015","article-title":"Utility of immunohistochemistry for \u03b1-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy","volume":"35","author":"Farinola","year":"2004","journal-title":"Hum Pathol"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.semdp.2005.11.001","article-title":"Immunohistochemistry in diagnostic surgical pathology of the prostate","volume":"22","author":"Hameed","year":"2005","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-199604000-00004","article-title":"Prostatic carcinoma with abundant xanthomatous cytoplasm: foamy gland carcinoma","volume":"20","author":"Nelson","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081300440763300_i1543-2165-144-3-326-b23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.anndiagpath.2014.07.002","article-title":"Foamy gland carcinoma in core needle biopsies of the prostate: clinicopathologic and immunohistochemical study of 56 cases","volume":"18","author":"Koca","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"2020081300440763300_i1543-2165-144-3-326-b24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000478-200105000-00008","article-title":"Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis","volume":"25","author":"Tran","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2020081300440763300_i1543-2165-144-3-326-b25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e318293d85b","article-title":"Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative \u03b1-methylacyl-CoA racemase vs. ERG expression","volume":"37","author":"Warrick","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020081300440763300_i1543-2165-144-3-326-b26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.humpath.2011.09.009","article-title":"Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome","volume":"43","author":"Hudson","year":"2012","journal-title":"Hum Pathol"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/00313021003767314","article-title":"Rare histological patterns of prostatic ductal adenocarcinoma","volume":"42","author":"Lee","year":"2010","journal-title":"Pathology"},{"key":"2020081300440763300_i1543-2165-144-3-326-b28","first-page":"115","article-title":"Pseudoneoplastic lesions of the prostate","author":"Humphrey","year":"2014","journal-title":"Neoplastic Mimics in Genitourinary Pathology"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0046-8177(94)90147-3","article-title":"Prostatic xanthoma: a mimic of prostatic adenocarcinoma","volume":"25","author":"Sebo","year":"1994","journal-title":"Hum Pathol"},{"issue":"8","key":"2020081300440763300_i1543-2165-144-3-326-b30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/PAS.0b013e31802be3c2","article-title":"Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma","volume":"31","author":"Chuang","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081300440763300_i1543-2165-144-3-326-b31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ajcp\/95.3.330","article-title":"Granulomatous prostatitis and poorly differentiated prostate carcinoma: their distinction with the use of immunohistochemical methods","volume":"95","author":"Presti","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"2020081300440763300_i1543-2165-144-3-326-b32","first-page":"724","article-title":"Granulomatous prostatitis on needle biopsy","volume":"121","author":"Oppenheimer","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2020081300440763300_i1543-2165-144-3-326-b33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anndiagpath.2008.04.006","article-title":"Foamy gland microcarcinoma in needle prostatic biopsy","volume":"12","author":"Arista-Nasr","year":"2008","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"2020081300440763300_i1543-2165-144-3-326-b34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/00000478-199810000-00009","article-title":"Pseudohyperplastic prostatic adenocarcinoma","volume":"22","author":"Humphrey","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/PAS.0000000000000193","article-title":"Histologic features of pseudohyperplastic perineural invasion in prostatic adenocarcinoma: a mimicker of benign hyperplastic glands and high-grade prostatic intraepithelial neoplasia","volume":"38","author":"So","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anndiagpath.2015.04.009","article-title":"Pseudohyperplastic prostate carcinoma: histologic patterns and differential diagnosis","volume":"19","author":"Arista-Nasr","year":"2015","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"2020081300440763300_i1543-2165-144-3-326-b37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00000478-200008000-00001","article-title":"Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy","volume":"24","author":"Levi","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1066896916640360","article-title":"Pseudohyperplastic adenocarcinoma with foamy changes in needle prostate biopsy and prostatectomy","volume":"24","author":"Arista-Nasr","year":"2016","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"2020081300440763300_i1543-2165-144-3-326-b39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/1066896917715910","article-title":"Minimal (limited) pseudohyperplastic prostatic adenocarcinoma in needle prostatic biopsy","volume":"25","author":"Arista-Nasr","year":"2017","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-200306000-00007","article-title":"Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer","volume":"27","author":"Zhou","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2020081300440763300_i1543-2165-144-3-326-b41","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/PAS.0b013e3182495dee","article-title":"Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue","volume":"36","author":"Gottipati","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2559.2011.04079.x","article-title":"Therapy-associated effects in the prostate gland","volume":"60","author":"Srigley","year":"2012","journal-title":"Histopathology"},{"issue":"1","key":"2020081300440763300_i1543-2165-144-3-326-b43","first-page":"107","article-title":"Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma","volume":"22","author":"Petraki","year":"2007","journal-title":"Histol Histopathol"},{"issue":"suppl 1","key":"2020081300440763300_i1543-2165-144-3-326-b44","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","article-title":"Treatment effects in prostate cancer","volume":"31","author":"Evans","year":"2018","journal-title":"Mod Pathol"},{"issue":"7","key":"2020081300440763300_i1543-2165-144-3-326-b45","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(19950401)75:7<1634::AID-CNCR2820750713>3.0.CO;2-#","article-title":"Pathology of androgen deprivation therapy in prostate carcinoma: a comparative study of 173 patients","volume":"75","author":"Civantos","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1097-0142(19910815)68:4<821::AID-CNCR2820680426>3.0.CO;2-S","article-title":"Pathologic changes associated with androgen deprivation therapy for prostate cancer","volume":"68","author":"Murphy","year":"1991","journal-title":"Cancer"},{"issue":"4","key":"2020081300440763300_i1543-2165-144-3-326-b47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1309\/H4JX0XEHDAC8YL3P","article-title":"Altered expression of \u03b1-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy","volume":"123","author":"Suzue","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081300440763300_i1543-2165-144-3-326-b48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2006.08.016","article-title":"\u03b1-methylacyl-CoA racemase (P504S)\/34\u03b2E12\/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy","volume":"38","author":"Sung","year":"2007","journal-title":"Hum Pathol"},{"issue":"10","key":"2020081300440763300_i1543-2165-144-3-326-b49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/00000478-199910000-00002","article-title":"Diagnosis of prostate cancer in needle biopsies after radiation therapy","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081300440763300_i1543-2165-144-3-326-b50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cncr.24020","article-title":"Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial","volume":"115","author":"Crook","year":"2009","journal-title":"Cancer"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/326\/2501131\/arpa_2019-0456-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/326\/2501131\/arpa_2019-0456-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:12Z","timestamp":1764790812000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/3\/article-p326.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,11,15]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0456-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}